Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
01/2012
01/24/2012US8101763 Method for producing scopine esters
01/19/2012WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof
01/19/2012WO2012006953A1 Oxazine derivatives and their use in the treatment of neurological disorders
01/19/2012WO2011103435A3 Methods for forming protected organoboronic acids
01/19/2012US20120016120 Process for producing 2-hydroxymethylmorpholine salt
01/19/2012US20120016118 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
01/19/2012US20120015947 Cyclic hydroxylamine as psychoactive compounds
01/19/2012US20120013246 Dendrimer and organic light-emitting device using the same
01/19/2012DE102010027218A1 Organische Komplexe enthaltend Metalle Organic complexes containing metals
01/19/2012CA2771928A1 Oxazine derivatives and their use in the treatment of neurological disorders
01/18/2012EP1506196B1 Pyrazolopyrimidines as sodium channel inhibitors
01/18/2012CN102325836A Oxazoline and/or oxazine compositions
01/18/2012CN102321044A Preparation method of 3-(2-bromo propionyl)-spiro[2H-1,3-benzoxazine-2,1'-cyclohexane]-4(3H)-one
01/18/2012CN102320988A 4-(4-amion phenyl)-3-morpholone intermediate amide and synthesis method and application thereof
01/12/2012WO2012004378A1 Spiro-cyclic amine derivatives as s1p modulators
01/12/2012WO2012004375A1 Bisaryl (thio)morpholine derivatives as s1p modulators
01/12/2012WO2011146821A3 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
01/12/2012US20120010202 Polymerizable benzoxazine compounds with interfacial active or surface active properties
01/12/2012US20120009683 Fluorescent Metal Ion Indicators with Large Stokes Shifts
01/12/2012CA2804329A1 Bisaryl (thio)morpholine derivatives as s1p modulators
01/12/2012CA2804143A1 Spiro-cyclic amine derivatives as s1p modulators
01/11/2012EP2403839A2 Neurotrophin mimetics and uses thereof
01/11/2012EP1994005B9 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
01/11/2012EP1730126B1 Novel benzoxazinone derivatives used as long-acting betamimetics for treating respiratory illnesses
01/11/2012CN102311378A Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related disorders
01/10/2012CA2436665C Nucleic acid derivatives
01/05/2012WO2012000608A2 Novel beta-aminoaldehyde derivatives, process for their preparation and their chemical use as reactive intermediates
01/05/2012WO2011130194A3 Methods for producing viloxazine salts and novel polymorphs thereof
01/05/2012US20120004232 2-amino-bicyclo(3.1.0) hexane-2, 6-dicarboxylic ester derivative
01/05/2012US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
01/05/2012US20120004206 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
01/05/2012US20120004165 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
01/05/2012US20120000118 Low-molecular weight polyisobutyl-substituted amines as dispersant boosters
01/04/2012EP2400968A1 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
01/04/2012CN102307878A 3,6-disubstituted xanthylium salts
01/03/2012CA2660917C Process for producing benzoxazine derivative and production intermediate thereof
01/03/2012CA2532458C Clear photopolymerizable systems for the preparation of high thickness coatings
01/03/2012CA2424102C Photo-labile pro-fragrance conjugates
12/2011
12/29/2011WO2011161128A1 Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
12/29/2011WO2011161030A1 Heterocyclic substituted methoxyphenyl derivatives having an oxo group, method for producing same, and use thereof as gpr40 receptor modulators
12/29/2011US20110319611 Benzoxazinone compound, method for producing the same, and pharmaceutical composition containing the same
12/29/2011US20110319403 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
12/28/2011EP2398855A2 Oxazoline and/or oxazine compositions
12/27/2011US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011US8084484 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
12/27/2011US8084450 Organic compounds
12/22/2011US20110313159 Camphor-derived beta-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same
12/22/2011US20110313155 Process of making 3-phenylimino-3h-phenoxazine mediator
12/22/2011US20110313154 Method for preparing phenylalanine derivatives having quinazoline-dione skeleton and intermediates for use in the preparation of the derivatives
12/22/2011US20110312965 Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
12/22/2011US20110312964 Cysteine protease inhibitors
12/22/2011US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
12/22/2011US20110309341 Amine polymer compound and light emitting device using the same
12/21/2011EP2155736B1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
12/21/2011CN101704796B 3-吗啉酮制备方法 3- morpholinone Preparation
12/20/2011US8080655 Methods of making efavirenz and intermediates thereof
12/20/2011CA2485136C Benzoxazine derivatives as 5-ht6 modulators and uses thereof
12/15/2011WO2011156655A2 Novel glp-1 receptor stabilizers and modulators
12/15/2011WO2011154827A2 Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
12/15/2011WO2011154678A1 Compounds
12/15/2011WO2011154431A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
12/15/2011WO2011154148A1 Novel therapeutic compounds
12/15/2011US20110306600 Novel therapeutic compounds
12/15/2011US20110306542 Novel glp-1 receptor stabilizers and modulators
12/15/2011US20110305632 Process for the preparation of asymmetrical bis(thiosemicarbazones)
12/15/2011CA2802295A1 Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
12/15/2011CA2799640A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
12/14/2011EP2394983A1 Process for making 3-substituted 2-amino-5-halobenzamides
12/14/2011CN102282129A 用于治疗癌症和免疫和自身免疫疾病的细胞程序死亡诱导药剂 Procedures for the treatment of cancer and cellular immune and autoimmune diseases inducing agent
12/13/2011US8076072 Nucleic acid labeling compounds
12/13/2011CA2539070C Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
12/08/2011WO2010073254A3 Process for preparing efavirenz polymorph
12/08/2011US20110301346 Process for the purification of amorolfine hydrochloride
12/08/2011US20110301156 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof to Treat Pain and Other Conditions
12/08/2011US20110301149 Compositions and methods for treating alcohol use disorders, pain and other diseases
12/08/2011US20110300074 3,6-disubstituted xanthylium salts
12/07/2011EP2392562A1 Structural carotenoid analogs for the inhibition and amelioration of disease
12/07/2011CN102272110A 制备依法韦伦的方法 Efavirenz method of preparing
12/07/2011CN102268249A 一种可用肉眼检测汞离子的荧光探针及其制备方法和应用 A visual inspection of mercury ions fluorescent probe and its preparation method and application available
12/07/2011CN101395144B 制备苯并噁嗪酮的方法 Preparation method of benzoxazinone
12/01/2011WO2011147279A1 Preparation method of 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazole-3-one
12/01/2011US20110294787 Substituted thiomorpholine derivatives
11/2011
11/30/2011EP2389371A2 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
11/30/2011CN102264732A PI3K/mTOR激酶抑制剂 PI3K / mTOR kinase inhibitor
11/30/2011CN102260224A 一种合成2-吗啉酮衍生物的方法 A Synthesis of 2-morpholin-one derivative
11/30/2011CN101812033B 布洛芬2-芳基吗啉乙酯及其制备方法与应用 Ibuprofen 2-aryl-morpholino ethyl and its preparation method and application
11/29/2011US8067410 Phenolic and catecholic amines and prodrugs thereof
11/29/2011CA2380359C Process for producing benzoxazine derivative and production intermediate thereof
11/24/2011WO2011146850A1 Phenylmorpholines and analogues thereof
11/24/2011WO2011146821A2 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
11/24/2011WO2011145669A1 Amide derivative
11/24/2011CA2800220A1 Phenylmorpholines and analogues thereof
11/24/2011CA2800219A1 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
11/23/2011EP2388252A1 Process for producing 2-hydroxymethylmorpholine salt
11/23/2011EP2387560A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/23/2011CN102250034A Method for extracting dimboa serving as active secondary metabolite in corn
11/22/2011US8063205 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue
11/17/2011US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/17/2011US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/16/2011EP2259689B1 Flavor molecules
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 112